Blockade of the protease ADAM17 ameliorates experimental pancreatitis

Acute and chronic pancreatitis, the latter associated with fibrosis, are multifactorial inflammatory disorders and leading causes of gastrointestinal disease-related hospitalization. Despite the global health burden of pancreatitis, currently, there are no effective therapeutic agents. In this regar...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Proceedings of the National Academy of Sciences - PNAS Ročník 119; číslo 42; s. e2213744119
Hlavní autori:	Saad, Mohamed I, Weng, Teresa, Lundy, Joanne, Gearing, Linden J, West, Alison C, Harpur, Christopher M, Alanazi, Mohammad, Hodges, Christopher, Croagh, Daniel, Kumar, Beena, Sagi, Irit, Rose-John, Stefan, Jenkins, Brendan J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 18.10.2022
Predmet:	Acute Disease ADAM17 Protein - genetics ADAM17 Protein - metabolism Animals Carcinogens Ceruletide - toxicity Cytokines Disintegrins Endopeptidases Fibrosis Interleukin-6 - genetics Interleukin-6 - metabolism Ketones Mice Nicotine Nitrosamines Pancreatitis - drug therapy Pancreatitis - genetics Peptide Hydrolases Tumor Necrosis Factor-alpha - metabolism apoptosis ADAM17 pancreatitis ADAM17 prodomain inhibitor inflammation
ISSN:	1091-6490, 1091-6490
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!